Search

Search Results
Results 5481 - 5490 of 8685 for Dementia
  • Drug - 15 May 2024
    Consumer Medicine Information (CMI) about Trisequens (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • News - 14 May 2024
    In early 2020, with reports of covid-19 outbreaks making dire headlines, Trever Schapers worried about her father's safety in a nursing home in Queens.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Kliovance (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Kliogest (Estradiol/Norethisterone acetate) intended for persons living in Australia.
  • Equipment - 22 Feb 2024
    Qunaterix's NF-LIGHTTM Neurofilament (NfL) Chain Assay can advance neurological research from the discovery stage to diagnosis using neurofilament light.
  • News - 15 Feb 2024
    A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 3, entitled, "GV1001 reduces...
  • Equipment - 2 Feb 2024
    This product profile describes the features and applications of the Amplivox BEEP Lead generation & screening audiometry solution.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Femoston-Conti intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Femoston 2/10 intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Femoston 1/10 intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.